
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19052239
[patent_doc_number] => 20240094208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/461820
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461820
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/461820 | MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors | Sep 5, 2023 | Pending |
Array
(
[id] => 21010801
[patent_doc_number] => 12747276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-29
[patent_title] => Peptide used for immunotherapeutics
[patent_app_type] => utility
[patent_app_number] => 18/242653
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 45036
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242653
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242653 | PEPTIDE USED FOR IMMUNOTHERAPEUTICS | Sep 5, 2023 | Pending |
Array
(
[id] => 19187776
[patent_doc_number] => 20240166689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => PEPTIDE-COMPOUND CYCLIZATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/460300
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 161024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460300
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460300 | Peptide-compound cyclization method | Aug 31, 2023 | Issued |
Array
(
[id] => 18817486
[patent_doc_number] => 20230391826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/172116
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18172116
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/172116 | COMPOSITIONS AND METHODS FOR TREATING DISEASES | Aug 27, 2023 | Pending |
Array
(
[id] => 19140492
[patent_doc_number] => 20240139281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => USE OF GOJI GLYCOPEPTIDE IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 18/236085
[patent_app_country] => US
[patent_app_date] => 2023-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18236085
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/236085 | USE OF GOJI GLYCOPEPTIDE IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | Aug 20, 2023 | Pending |
Array
(
[id] => 18816016
[patent_doc_number] => 20230390355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => COMPOSITIONS AND METHODS RELATING TO ALOPECIA
[patent_app_type] => utility
[patent_app_number] => 18/234795
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18234795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/234795 | COMPOSITIONS AND METHODS RELATING TO ALOPECIA | Aug 15, 2023 | Pending |
Array
(
[id] => 18939613
[patent_doc_number] => 20240034752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => ARTIFICIAL SHORT INTERFERING PEPTIDE FOR THE PHOSPHORYLATION SUBSTRATE OF DAPK1 AND ITS PHARMACEUTICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/447364
[patent_app_country] => US
[patent_app_date] => 2023-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18447364
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/447364 | ARTIFICIAL SHORT INTERFERING PEPTIDE FOR THE PHOSPHORYLATION SUBSTRATE OF DAPK1 AND ITS PHARMACEUTICAL APPLICATIONS | Aug 9, 2023 | Pending |
Array
(
[id] => 19050874
[patent_doc_number] => 20240092843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PEPTIDES AND METHODS FOR THE TREATMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 18/446172
[patent_app_country] => US
[patent_app_date] => 2023-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18446172
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/446172 | Peptides and methods for the treatment of diabetes | Aug 7, 2023 | Issued |
Array
(
[id] => 19793370
[patent_doc_number] => 12234300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Conjugated hepcidin mimetics
[patent_app_type] => utility
[patent_app_number] => 18/366558
[patent_app_country] => US
[patent_app_date] => 2023-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 38052
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18366558
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/366558 | Conjugated hepcidin mimetics | Aug 6, 2023 | Issued |
Array
(
[id] => 18751606
[patent_doc_number] => 20230354820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => ANTI-PEST TOXINS AND CELLS
[patent_app_type] => utility
[patent_app_number] => 18/217660
[patent_app_country] => US
[patent_app_date] => 2023-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18217660
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/217660 | ANTI-PEST TOXINS AND CELLS | Jul 2, 2023 | Pending |
Array
(
[id] => 19265345
[patent_doc_number] => 20240209044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => PEPTIDE KINASE INHIBITORS AND ACTIVATORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/335156
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/335156 | PEPTIDE KINASE INHIBITORS AND ACTIVATORS AND METHODS OF USE THEREOF | Jun 14, 2023 | Pending |
Array
(
[id] => 18844481
[patent_doc_number] => 20230406885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => CYCLIC PEPTIDES FOR TRAPPING INTERLEUKIN-1 BETA
[patent_app_type] => utility
[patent_app_number] => 18/333628
[patent_app_country] => US
[patent_app_date] => 2023-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333628
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/333628 | CYCLIC PEPTIDES FOR TRAPPING INTERLEUKIN-1 BETA | Jun 12, 2023 | Pending |
Array
(
[id] => 18830840
[patent_doc_number] => 20230399365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => Bacterial Effector as Anti-Bacterial Protein
[patent_app_type] => utility
[patent_app_number] => 18/331686
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331686
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/331686 | Bacterial Effector as Anti-Bacterial Protein | Jun 7, 2023 | Issued |
Array
(
[id] => 20023184
[patent_doc_number] => 20250161406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => PREVENTING ALU SINES-MEDIATED PATHOLOGIES
[patent_app_type] => utility
[patent_app_number] => 18/872790
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18872790
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/872790 | PREVENTING ALU SINES-MEDIATED PATHOLOGIES | Jun 5, 2023 | Pending |
Array
(
[id] => 19020097
[patent_doc_number] => 20240076268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => Polypeptide Integrin Antagonists
[patent_app_type] => utility
[patent_app_number] => 18/317017
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317017
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317017 | Polypeptide Integrin Antagonists | May 11, 2023 | Abandoned |
Array
(
[id] => 19049344
[patent_doc_number] => 20240091313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => MODIFIED VASOACTIVE INTESTINAL PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/311049
[patent_app_country] => US
[patent_app_date] => 2023-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311049
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311049 | MODIFIED VASOACTIVE INTESTINAL PEPTIDES | May 1, 2023 | Abandoned |
Array
(
[id] => 18610947
[patent_doc_number] => 20230277677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => POLYMERIC CONJUGATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/140681
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140681 | POLYMERIC CONJUGATES AND USES THEREOF | Apr 27, 2023 | Pending |
Array
(
[id] => 20256119
[patent_doc_number] => 12428462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Recombinant CDHR3 protein fragments inhibit rhinovirus C binding and replication
[patent_app_type] => utility
[patent_app_number] => 18/306911
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 15489
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18306911
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/306911 | Recombinant CDHR3 protein fragments inhibit rhinovirus C binding and replication | Apr 24, 2023 | Issued |
Array
(
[id] => 19526695
[patent_doc_number] => 20240350597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => PROTEASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/138612
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138612
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138612 | PROTEASE INHIBITORS | Apr 23, 2023 | Pending |
Array
(
[id] => 20256124
[patent_doc_number] => 12428467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Gelatin particles, method for producing gelatin particles, gelatin particle-containing cell, and method for producing gelatin particle-containing cell
[patent_app_type] => utility
[patent_app_number] => 18/304159
[patent_app_country] => US
[patent_app_date] => 2023-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1708
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18304159
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/304159 | Gelatin particles, method for producing gelatin particles, gelatin particle-containing cell, and method for producing gelatin particle-containing cell | Apr 19, 2023 | Issued |